Globe Newswire
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike proteinThe spike protein is the target of many COVID-19 vaccines in developmentThis test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19 Basel, 2 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today…
Source link
